Apodemus AB is a Swedish pharmaceutical company focused on the development of antiviral treatments and diagnostic tools for viral infections.
We work according to the hypothesis that “A new virus group is the common environmental factor that underlie a wide range of diseases and that these diseases can be treated by antiviral therapy”.
Apodemus is non-public, privately owned, small pharmaceutical company. We are focused on basic research; identifying and characterizing new viruses, development of viral diagnostic tools and antiviral treatments.
Apodemus fulfills the SME (small and medium size enterprise) criteria and has granted SME status by the European Medicines Agency (EMA).